Russian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

rhinitis/ожирение

Ссылка сохраняется в буфер обмена
Страница 1 от 18 полученные результаты

Phenylpyrrole derivative

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
CROSS REFERENCE TO RELATED APPLICATIONS This application is a National Stage of International Application No. PCT/JP2012/081744 filed Dec. 7, 2012, claiming priority based on Japanese Patent Application No. 2011-268561 filed Dec. 8, 2011, the contents of all of which are incorporated herein by

Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
TECHNICAL FIELD The present invention relates to a nitrogen-containing bicyclic compound or a pharmacologically acceptable salt thereof and a pharmaceutical composition comprising it as active ingredient. More specifically, the present invention relates to (1) a compound of formula (I) ##STR00002##

Dihydroquinolinone derivatives

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
CROSS REFERENCE TO RELATED APPLICATIONS This application is a National Stage of International Application No. PCT/JP2010/052114 filed Feb. 5, 2010, claiming priorities based on Japanese Patent Application Nos. 2009-25462 filed Feb. 6, 2009 and 2009-146735 filed Jun. 19, 2009, the contents of all of

N-acyl amino acid derivatives, a method for the preparation thereof, a pharmaceutical composition and use thereof as anti-allergic, anti-inflammatory and hypolipidemic agents

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
The present invention relates to the field of bioorgmic chemistry and concerns N-acyl derivatives of amino acids and pharmaceutically acceptable salts thereof, novel processes for synthesis of said compounds as well as pharmaceutical compositions based on them and use thereof in medicine as

N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form anti-allergic, anti-inflammatory and hypolipidemic agents

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
The present invention relates to the field of bioorganic chemistry and concerns N-acyl derivatives of amino acids and pharmaceutically acceptable salts thereof, novel processes for synthesis of said compounds as well as pharmaceutical compositions based on them and use thereof in medicine as

Phenylpyrazole derivatives

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
CROSS REFERENCE TO RELATED APPLICATIONS This application is a National Stage of International Application No. PCT/JP2008/070712 filed Nov. 13, 2008, claiming priorities based on Japanese Patent Application No. 2007-294040 filed Nov. 13, 2007 and 2008-153736 filed Jun. 12, 2008, the contents of all

Phenylpyrazole derivatives

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND ART Histamine is usually stored within intracellular granules in mast cells, lung, liver and gastric mucosa, etc. In response to external stimuli such as antigen binding to cell surface antibody, histamine is released into the extracellular environment. For example, when mast cells are

Phenylpyrazole derivatives

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND ART Histamine is usually stored within intracellular granules in mast cells, lung, liver and gastric mucosa, etc. In response to external stimuli such as antigen binding to cell surface antibody, histamine is released into the extracellular environment. For example, when mast cells are

Histamine-3 receptor antagonists

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION This invention is directed to compounds of formula I described herein, to a pharmaceutical composition comprising such compounds, and to methods of treatment of disorders or conditions that may be treated by antagonizing histamine-3 (H3) receptors using such compounds.

Histamine-3 receptor modulators

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
The entire disclosure of parent application 60/541,151 filed Feb. 2, 2004 is fully incorporated herein by reference thereto. BACKGROUND OF THE INVENTION This invention is directed to compounds of formula I described herein, to pharmaceutical composition comprising such compounds, and to methods of

Histamine-3 receptor antagonists

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION This invention is directed to compounds of formula I described herein, to a pharmaceutical composition comprising such compounds, to a process of preparation of such compounds, and to methods of treatment of disorders or conditions that may be treated by antagonizing

Histamine-3 receptor antagonists

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION This invention is directed to compounds of formula I described herein, to a pharmaceutical composition comprising such compounds, to a process of preparation of such compounds, and to methods of treatment of disorders or conditions that may be treated by antagonizing

Toluene sulfonic acid salt of a therapeutic compound and pharmaceutical compositions thereof

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
The present invention is directed to the tosylate salt of the compound of formula 1, as described herein, to a pharmaceutical composition comprising this salt, and to methods of treatment of disorders or conditions that may be treated by antagonizing histamine-3 (H.sub.3) receptors using the

Tosylate salt of trans-N-isobutyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-yl-methyl)-phenyl] cyclobut anecarboxamide

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
The present invention is directed to the tosylate salt of the compound of formula 1 as described herein, to a pharmaceutical composition comprising this preferred salt, and to methods of treatment of disorders or conditions that may be treated by antagonizing histamine-3 (H.sub.3) receptors using

Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitors

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
The present invention relates to compounds that are inhibitors of cysteine proteinases, pharmaceutical compositions containing said compounds, and their use in therapy. More specifically, the invention relates to compounds that are inhibitors of cathepsin S, a cysteine proteinase of the CA clan.
Присоединяйтесь к нашей
странице facebook

Самая полная база данных о лекарственных травах, подтвержденная наукой

  • Работает на 55 языках
  • Травяные лекарства, подтвержденные наукой
  • Распознавание трав по изображению
  • Интерактивная карта GPS - отметьте травы на месте (скоро)
  • Прочтите научные публикации, связанные с вашим поиском
  • Ищите лекарственные травы по их действию
  • Организуйте свои интересы и будьте в курсе новостей исследований, клинических испытаний и патентов

Введите симптом или заболевание и прочтите о травах, которые могут помочь, введите лекарство и узнайте о болезнях и симптомах, против которых оно применяется.
* Вся информация основана на опубликованных научных исследованиях.

Google Play badgeApp Store badge